Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: A systematic review

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 32, Issue 2, 2012, Pages 131-139

  Cortes Bergoder, Mery ^a   Thomas, Randal J ^a   Albuquerque, Felipe N ^a   Batsis, John A ^b,c   Burdiat, Gerard ^d   Perez Terzic, Carmen ^a   Trejo Gutierrez, Jorge ^e   Lopez Jimenez, Francisco ^a  

^a MAYO CLINIC   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d Centro Calidad de Vida   (Uruguay)

^e MAYO CLINIC   (United States)

Author keywords

Cardiovascular diseases; Hispanic Americans; Latin America; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASE; DATABASE; HEALTH RISK; LITERATURE REVIEW; PUBLIC HEALTH; RISK FACTOR; WORLD HEALTH ORGANIZATION;

AREA UNDER THE CURVE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; FOLLOW UP; HISPANIC; HUMAN; PROGNOSIS; REPRODUCIBILITY; REVIEW; RISK; RISK ASSESSMENT; SOUTH AND CENTRAL AMERICA; STATISTICS; THEORETICAL MODEL; UNITED STATES;

AREA UNDER CURVE; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; LATIN AMERICA; MODELS, THEORETICAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK; RISK ASSESSMENT; UNITED STATES;

LATIN AMERICA; UNITED STATES;

EID: 84868032866     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892012000800007     Document Type: Review

References (32)

1. United States Census Bureau. Overview of race and Hispanic origin, 2010. Available at: http://www.census.gov/prod/cen2010/ briefs/c2010br-02.pdf Accessed on 12 January 2012.
2. American Heart Association. International cardiovascular disease statistics, 2004. Available at: http://www.muschealth.com/heart/ 2004StatUpdate.pdf Accessed on 12 January 2012.
3. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115(9):1067-74.
4. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121(1):58-65.
5. Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010;3(2):181-7.
6. Barcelo A. Cardiovascular diseases in Latin America and the Caribbean. Lancet. 2006; 368(9536):625-6.
7. American Heart Association. Heart disease and stroke statistics, 2010. Available at: http://my.americanheart.org/idc/groups/ ahamah-public/@wcm/@sop/ documents/ downloadable/ucm-319689.pdf Accessed on 10 August 2011.
8. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007;82(5):509-24.
9. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Hazuda HP. All-cause and cardiovascular mortality among Mexican- American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox." Am J Epidemiol. 2003;158(11):1048-57.
10. Batsis JA, Lopez-Jimenez F. Cardiovascular risk assessment-from individual risk prediction to estimation of global risk and change in risk in the population. BMC Med. 2010; 8(May 25):29.
11. Eichler K, Puhan MA, Steurer J, Bachmann LM. Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J. 2007;153(5):722-31.
12. Suka M, Sugimori H, Yoshida K. Application of the updated Framingham risk score to Japanese men. Hypertens Res. 2001;24(6):685-9.
13. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordon F, et al. Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp de Cardiol. 2003; 56(3):253-61.
14. Liu J, Hong Y, D'Agostino RB Sr., Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291(21):2591-9.
15. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105(3):310-5.
16. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611-9.
17. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Euro Heart J. 2003;24(11):987-1003.
18. Jimenez-Corona A, Lopez-Ridaura R, Williams K, Gonzalez-Villalpando ME, Simon J, Gonzalez-Villalpando C. Applicability of Framingham risk equations for studying a low-income Mexican population. Salud publica Mex. 2009;51(4):298-305.
19. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
20. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83(1):356-62.
21. Montalvo G, Avanzini F, Anselmi M, Prandi R, Ibarra S, Marquez M, et al. Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification. BMJ. 2008;337: 1387.
22. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, et al. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Clin Exp Hypertens. 1999;21(5-6):1009-60.
23. Rassi A Jr., Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006; 355(8):799-808.
24. D'Agostino RB, Sr., Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-7.
25. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003; 327(7426):1267.
26. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24(21):1903-11.
27. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24(10):937-45.
28. Icaza G, Nunez L, Marrugat J, Mujica V, Escobar MC, Jimenez AL, et al. Estimación de riesgo de enfermedad coronaria mediante la función de Framingham adoptada para la población chilena. Rev Med de Chil. 2009; 137(10):1273-82.
29. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up study cohort. Lancet. 2008;371(9616):923-31.
30. Sorlie PD, Aviles-Santa LM, Wassertheil- Smoller S, Kaplan RC, Daviglus ML, Giachello AL, et al. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20(8):629-41.
31. Rubinstein AL, Irazola VE, Poggio R, Bazzano L, Calandrelli M, Lanas Zanetti FT, et al. Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: the CESCAS I study. BMJ Open. 2011;1(1):e000126.
32. Aquino EM, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol. 2012;175(4):315-24.